The QualityStocks Daily Stock List
- Mount TAM Biotechnologies, Inc. (MNTM)
- Harvest Health & Recreation, Inc. (HRVSF)
- Predictive Technology Group, Inc. (PRED)
- Body and Mind, Inc. (BMMJ)
- BT Group plc (BTGOF)
- MariMed, Inc. (MRMD)
- Veritas Farms, Inc. (VFRM)
- EOS, Inc. (EOSS)
- Almost Never Films, Inc. (HLWD)
- Kutcho Copper Corp. (KCCFF)
- HedgePath Pharmaceuticals, Inc. (HPPI)
- Regulus Therapeutics, Inc. (RGLS)
- EPHS Holdings, Inc. (STNN)
- WRIT Media Group, Inc. (WRIT)
Mount TAM Biotechnologies, Inc. (MNTM)
Street Insider, Investment Pitch Media, Market Wire News, 4-Traders, Stock Target Advisor, Wallet Investor, Last10k, Stockopedia, Stockhouse, and Simply Wall St reported earlier on Mount TAM Biotechnologies, Inc. (MNTM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Mount TAM Biotechnologies, Inc. formed to develop, optimize and bring to market novel pharmaceutical products. These products are to improve the health and well-being of patients suffering from a range of serious disease states where there is significant unmet need. The Company’s most advanced compound is undergoing development to treat systemic lupus erythematosus (SLE), TAM-01. Established in 2014, Mount TAM Biotechnologies is headquartered at the Buck Institute, Marin County, California.
A specialty biopharmaceutical company, Mount TAM’s emphasis is on the discovery and development of novel mTOR modulators to address serious unmet need across a range of therapeutic areas. The Company’s mission is to provide premier leadership in the field of mTOR modulators.
Mount TAM Biotechnologies combines its research collaboration with the world-renowned Buck Institute for Research on Aging, its proprietary discovery platform, and its lead compound targeting systemic lupus erythematosus (SLE), TAM-01, to bring a unique focus and value proposition to the biotechnology space.
The Company’s drug discovery platform is founded on its proprietary approach to the development of novel ‘rapalogs’ (rapamycin-like molecules). These deliver greater mTORC1 selectivity in comparison to presently marketed compounds. mTORC1 is one of the complexes formed by mTOR, a master regulator of cell growth and metabolism. Mount TAM’s platform permits the Company to quickly engineer new compounds with superior mTORC1 selectivity and to rapidly screen them for efficacy across a range of disease states.
Mount TAM Biotechnologies concentrates on bringing to bear its inventive combination of expertise in the science of mTOR modulation, medicinal chemistry and pre-clinical and clinical development to address serious unmet need. The Company accomplishes this through discovering and bringing into the clinic novel mTORC1 inhibitors, which have the potential to address a wide spectrum of diseases. These include autoimmune disease, neurodegenerative disease, and several rare genetic diseases where mTORC1 activity is known to be increased.
Mount TAM’s TAM-01 has undergone extensive pre-clinical testing to validate its potential in systemic lupus erythematosus (SLE). TAM-01 is ready for the final steps necessary to file an investigational new drug application (IND). These steps include cGMP manufacturing and GLP Tox studies.
Mount TAM Biotechnologies, Inc. (MNTM), closed Tuesday's trading session at $0.03, up 8.89%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 9,698 and the stock's 52-week low/high is $0.0051/$0.068.
Harvest Health & Recreation, Inc. (HRVSF)
New Cannabis Ventures, Market Screener, Insider Financial, InvestorsHub, Trading View, Dividend Investor, Proactive Investors, Cannabis Business Times, Profit Confidential, Cannabis Stock Trades, Stock Target Advisor, Street Signals, Stockwatch, Micro Cap Daily, Micro Small Cap, MarketWatch, Midas Letter, NIC Investors, and Stockhouse reported earlier on Harvest Health & Recreation, Inc. (HRVSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Harvest Health & Recreation, Inc. is a vertically integrated cannabis based in Tempe, Arizona. It has one of the largest and deepest footprints in the USA. The Company is a multi-state cannabis operator (MSO) and vertically-integrated cannabis enterprise. Harvest Health & Recreation cultivates, manufactures, and retails cannabis in the U.S. The Company lists on the OTC Markets Group’s OTCQX.
Harvest Health & Recreation has been recognized for superior quality with 9 dispensary awards and 5 product awards. The Company’s emphasis is quality product lines, built through meticulous product testing. This results in best-in-class products. Harvest Health & Recreation has been dedicated since 2011 to aggressively expanding its Harvest House of Cannabis retail and wholesale presence across the U.S., acquiring, creating and growing leading brands for patients and consumers nationally, and continuing on a path of profitable growth. Subject to the completion of announced acquisitions, the Company will have the largest presence in the U.S., with rights to 210 facilities, of which 140 are retail locations and more than 1,580 employees across 17 States.
Harvest Health & Recreation holds the largest market share in the State of Arizona. It has a strong presence in 10 other States. It is on course to have 100 dispensaries in 14 States by 2020.
Harvest Health & Recreation announced recently that it signed a Definitive Agreement to acquire Verano Holdings to become one of the most diversified U.S. cannabis operators. The Company would become the largest multi-state operator (MSO) in the U.S. following closing of a Definitive Agreement signed on April 22, 2019 to acquire Verano Holdings, LLC, as previously announced by press release dated March 11, 2019. Verano Holdings is one of the largest privately held multi-state, vertically integrated licensed operators of cannabis facilities with an extensive portfolio of premium branded products.
Earlier this month, Harvest Health & Recreation announced the opening of its third, fourth and fifth Florida medical marijuana dispensaries. The Company holds licenses in Florida for up to 35 medical dispensaries, one cultivation facility, one manufacturing facility, and has operational dispensaries in the Orlando and Tallahassee markets.
Harvest Health & Recreation has been awarded a dispensary license to operate in Pasadena, (subject to the local Conditional Use Permit process and State regulatory requirements), marking the seventh California license for the Company. Harvest was among the top-scoring applicants from a pool of 128 applications to obtain licenses in the city.
It received top recognition for its high-level of sophistication, best-in-class experience, and world-renowned team of experts in operating quality-driven retail stores with a focus on bettering the community. Mr. Steve White, Chief Executive Officer of Harvest Health & Recreation, Inc., holds 100 percent ownership of the winning license entity, Harvest of Pasadena, LLC, for the benefit of Harvest Health & Recreation, Inc.
Harvest Health & Recreation, Inc. (HRVSF), closed Tuesday's trading session at $6.03, up 2.55%, on 172,129 volume with 497 trades. The average volume for the last 3 months is 428,248 and the stock's 52-week low/high is $0.075/$10.85.
Predictive Technology Group, Inc. (PRED)
NetworkNewsWire, Zacks, InvestorsHub, Insider Financial, Wallet Investor, Stockhouse, Wallmine, Infront Analytics, The Street, StreetWise Reports, Dividend Investor, and Simply Wall St reported earlier on Predictive Technology Group, Inc. (PRED), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Predictive Technology Group, Inc. is a therapeutics and life sciences company headquartered in Salt Lake City, Utah. It is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through inventive novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The Company formerly went by the name Global Enterprises Group, Inc. It changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group lists on the OTC Markets.
The Company’s wholly-owned subsidiaries are Predictive Therapeutics and Predictive Biotech. Through these, it focuses on four primary clinical categories. These are Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Laboratories concentrates on clinical and discovery work for human infertility and genetic conditions affecting women and children. Testing is performed using state-of-the-art instrumentation at its CAP and CLIA accredited facility.
Further to Predictive Biotech’s efforts to advance regenerative medicine, Predictive Therapeutics’ dedication is to assisting women in overcoming the devastating consequences of endometriosis through appropriate early-stage diagnosis and subsequent treatment. Subsidiary Predictive Biotech is a leader in human cell and tissue products for use in regenerative medicine. A growing national network of clinics, health systems, researchers and physicians take advantage of Predictive Biotech’s four main placental-derived and Wharton’s jelly umbilical cord-derived products (AmnioCyte™, AmnioCyte Plus™, PolyCyte™, CoreCyte™).
Predictive Technology Group recently announced that its wholly-owned subsidiary, Predictive Laboratories, reached an enrollment milestone of 200 participants in its ongoing Institutional Review Board (IRB)-approved study of spine and joint disease leading to chronic pain. Predictive Laboratories is the sponsor of the study. Kenneth Ward, MD, Laboratory Director of Predictive Laboratories, serves as Principal Investigator.
The primary objective of the IRB study is to conduct genetic research related to healthcare advancement in the diagnosis, treatment and prevention of conditions causing chronic pain. The first 200 participants have volunteered for the study by submitting their DNA samples to the Predictive Biorepository and by reporting detailed medical information through their healthcare providers.
Last month, Predictive Technology announced the signing of a letter of intent (LOI) with IQVIA (Formerly Quintiles and IMS) to guide the regulatory strategy for its wholly-owned subsidiary Predictive Biotech. The collaboration will expedite the process of identifying and executing the appropriate regulatory pathways for the Company’s existing products and future product candidates.
Earlier this month, Predictive Technology Group announced that Douglas S. Rabin, MD, has joined Predictive Laboratories as Vice President of Medical Affairs, Women’s Health. In this newly created position, Dr. Rabin will provide critical medical affairs support for the women's health clinical franchise. He has over 25 years of experience in women's healthcare. This includes clinical reproductive endocrinology, and obstetrics and gynecology.
Mr. Bradley Robinson, Predictive Technology Group Chief Executive Officer, said, “We welcome Dr. Rabin to the Predictive team to support our goal of commercializing our innovative, genetic-based diagnostics that are initially focus on human infertility and women’s health. Dr. Rabin is highly accomplished in launching pharmaceutical and diagnostic products at Fortune 500 companies. His experience and commitment to delivering improved, more comprehensive healthcare to patients will be of tremendous assistance in supporting our mission of employing advanced molecular diagnostics to prevent or eliminate disease for generations to come.”
Predictive Technology Group, Inc. (PRED), closed Tuesday's trading session at $4.50, down 2.81%, on 424,204 volume with 586 trades. The average volume for the last 3 months is 418,826 and the stock's 52-week low/high is $0.769/$6.909.
Body and Mind, Inc. (BMMJ)
Penny Stock Tweets, Dividend Investor, Wallmine, Market News Updates, PotStockNews, Investor Ideas, Stockhouse, MicroSmallCap, New Cannabis Ventures, Canadian Insider, Wallet Investor, GuruFocus, Trading View, Simply Wall St, The Street, Barchart, InvestorsHub, Insider Financial, Morningstar, and Midas Letter reported previously on Body and Mind, Inc. (BMMJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Body and Mind, Inc. invests in high quality medical and recreational cannabis cultivation, production and retail. The Company’s wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licences. In addition, Body and Mind holds cultivation and production licenses. Body and Mind (BaM) products include dried flower, edibles, topicals, extracts, and GPEN Gio cartridges. Body and Mind is based in Vancouver, British Columbia. The Company lists on the OTC Markets. Nevada Medical Group LLC (NMG Nevada) is a wholly-owned subsidiary of Body and Mind.
Body and Mind has collected, for many years’, elite cannabis plants from all over the world. Through carefully crossbreeding these plants, it has developed strains that give what it states are the perfect balance of body and mind benefits. Its cannabis plants are grown with hands-on care in small batches. Moreover, Body and Mind never uses synthetic pesticides. The Company offers an assortment of strains, available in flower, vapes, pre-rolls and concentrates.
This past March, Body and Mind announced expansion into Arkansas with in-State partner, Comprehensive Care Group LLC (CCG). The companies will work together to develop a medical marijuana dispensary facility in West Memphis, Arkansas. Medical marijuana dispensaries in Arkansas are licensed for retail sales and cultivation of up to 50 plants within the same facility.
Body and Mind has signed a long term lease to relocate its production facility to a new campus located within one mile of the Pepper Lane cultivation facility. The new facility is approximately 7,500 square feet. Body and Mind’s plan is to move the present production licence. It will not need to apply for a new license to produce edibles, oils and extracts.
Last week, Body and Mind announced it has started manufacturing in California via the Body and Mind California subsidiary NMG Cathedral City (NMG). The Company also announced expansion of the management team with the appointment of Sophia Hase as General Manager of the Cathedral City manufacturing operations. Since June of 2018, the Cathedral City facility has been producing THC (Tetrahydrocannabinol) distillate in bulk form. The facility is planned to be outfitted to manufacture popular Body and Mind products. This includes oils, wax, live resin, ambrosia, and also edibles.
Body and Mind, Inc. (BMMJ), closed Tuesday's trading session at $1.0795, up 1.84%, on 99,037 volume with 100 trades. The average volume for the last 3 months is 496,687 and the stock's 52-week low/high is $0.259/$2.70.
BT Group plc (BTGOF)
StockScores, stock2own, Invest Tribune, Macroaxis, Whale Wisdom, Investors Hangout, Teletrader, Trading View, Market Screener, Wallet Investor, Capital Cube, Stockhouse, Morningstar, and Barchart reported earlier on BT Group plc (BTGOF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
BT Group plc provides communications products and services in the United Kingdom (UK), Europe, the Middle East, Africa, the Americas, the Asia Pacific, and worldwide. It is one of the world's foremost communications services companies. BT is the largest provider of consumer fixed-line voice and broadband services in the UK. Incorporated in 2001, BT Group is headquartered in London, the UK.
In addition, the Company is the UK's largest mobile network operator, and is also the second largest pay-TV sports broadcaster in the UK. BT Group serves global multinational organizations with its security, cloud and networking services. Its focus is on helping 12 million homes and businesses go ultrafast by 2020.
BT Group provides products and services in approximately 180 countries. Internationally, the Company supplies managed networked IT (Information Technology) services to multinational corporations, domestic businesses, and national and local government organizations.
The Company has its BT Labs at Adastral Park. Launched in 1975, BT Labs at Adastral Park has been responsible for many of the cutting-edge innovations that have transformed the digital world. In 1984, BT Group’s research team at Adastral Park perfected the use of single mode optical fibre. Today, this technology plays a role at the core of all worldwide networks. Today, BT Labs at Adastral Park is where the Company’s 4,000 scientists, IT experts, engineers and collaboration partners are pushing the boundaries of innovation.
Furthermore, along with its partner TechHub, BT Group has established the BT Infinity Lab programme. It provides a front door for BT Group’s engagement with entrepreneurs and the start-up community - across the UK and beyond. The programme enables the Company to unleash the creativity and energy of the start-up community in a structured and highly-potent fashion. BT Infinity Lab formalizes the Company’s approach to identifying and amplifying the innovative ideas generated by free-thinking entrepreneurs.
BT Group operates in five segments. These are Consumer, Enterprise, Global, Openreach, and Technology. British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc. It encompasses virtually all businesses and assets of the BT Group.
Today, BT Group announced the opening of a new Cyber Security Operations Centre (Cyber SOC) in Paris, and also upgraded facilities, new customer solutions and recruitment at its existing SOCs in Madrid and Frankfurt. The new investments in the Company’s cyber security capabilities in Europe further enhance its position as a top provider of security services in the region and internationally.
The Paris Cyber SOC will provide advanced incident detection, threat intelligence, orchestration and automation services. BT’s global network of SOCs and 3,000 security specialists protect BT against 125,000 cyber-attacks per month, as well as offering solutions to consumers, governments and businesses.
BT Group plc (BTGOF), closed Tuesday's trading session at $2.61, up 28.57%, on 1,536 volume with 1 trade. The average volume for the last 3 months is 3,562 and the stock's 52-week low/high is $2.029/$3.96.
MariMed, Inc. (MRMD)
Micro Small Cap, CannabisNewsWire, Stock of the Week, CannabisMarketCap, Super Stock Screener, Stockhouse, PotStockNews, NIC Investors, Equity Clock, Daily Marijuana Observer, Profit Confidential, Trading View, MarketWatch, and Morningstar reported previously on MariMed, Inc. (MRMD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
MariMed, Inc. is a top multi-state cannabis operator centered on health and wellness. The OTCQB-listed Company’s commitment is to improving health and wellness with the highest quality hemp and cannabis products. It offers a complete range of cannabis products and operates state-of-the-art cannabis dispensaries in six States. In addition, MariMed has a separate division, MariMed Hemp, centered on the development of industrial hemp-derived CBD (cannabidiol) products. MariMed has its corporate office in Norwood, Massachusetts.
The Company is a first mover into the hemp CBD market with supply and products in the United States and the European Union (EU). MariMed’s focus is the continuing discovery of better wellness via cannabis and hemp. Its platform comprises a vertically integrated approach.
Regarding Seed-to-Sale, MariMed has wide-ranging experience with the broad variety of issues relevant to legal cannabis business activities. This includes licensing for cultivation, processing and dispensing. The Company holds 13 cannabis licenses for cultivation, production and dispensaries across 6 U.S. States. At present, MariMed is managing greater than 300,000 square feet of premier cannabis facilities.
Concerning its brands and products, the Company begins with a quality growing medium, rich genetics, and natural nutrients to formulate products for differing speeds and methods of delivery. MariMed’s products always include a broad assortment of dosing preferences and rich terpene profiles.
MariMed has extensive experience with the wide spectrum of issues attendant to legal cannabis business activities. This includes licensing for cultivation, processing and dispensing, litigation, banking and finance, raising and deploying capital, protecting intellectual property (IP), real estate development and leasing, and additional clickthroughs. Furthermore, the Company supports research and physician education, supported by the Scientific Advisory Board.
In May, MariMed announced 2019 Q1 results for the period ending March 31, 2019. Revenues grew 69 percent to $3.5 million, versus $2.1 million for Q1 2018. Gross Profit grew 90 percent to $2.2 million in comparison to $1.2 million for Q1 2018. Gross Profit as a percentage of Revenue grew from 57 percent in Q1 2018 to 64 percent in Q1 2019.
Reported Net Loss for the quarter was $23,211. This represents a 99 percent improvement over the $1.9 million loss for Q1 2018. On a per share basis, the first quarter was break even, versus a $.01 per share loss for the same period in 2018.
Yesterday, MariMed announced it is seeking a New Independent Director candidate.
Mr. Bob Fireman, MariMed Chief Executive Officer, stated: “The Company continues to execute on its strategic plan for consolidation and growth of its revenue and assets. It is important that the Company continues to seek additional outside independent directors with hands on expertise and experience germane to our industry and the dynamic growth our company continues to experience.”
MariMed, Inc. (MRMD), closed Tuesday's trading session at $2.25, up 7.66%, on 334,520 volume with 488 trades. The average volume for the last 3 months is 277,879 and the stock's 52-week low/high is $1.92/$5.80.
Veritas Farms, Inc. (VFRM)
Alpha Stock News, Market Wire News, Teletrader, Biz Journals, Stock Target Advisor, OTC.Watch, Street Insider, Simply Wall St, Stockwatch, Investors Hangout, Trader Social Network, GuruFocus, Trading View, GlobeNewswire, Stockhouse, and MarketWatch reported earlier on Veritas Farms, Inc. (VFRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.
A vertically-integrated agribusiness, Veritas Farms, Inc. concentrates on the production of full spectrum hemp extracts with naturally occurring cannabinoids. At present, it operates a 140-acre farm and production facilities in Pueblo, Colorado. The Company is registered with the Colorado Department of Agriculture to grow industrial hemp. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity. OTCQB-listed, Veritas Farms has its corporate headquarters in Fort Lauderdale, Florida.
Veritas Farms markets and sells products under its Veritas Farms™ brand. In addition, the Company manufactures private label products for several top distributors and retailers. Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in an array of size formats and flavors. Veritas produces the highest quality, full spectrum CBD (cannabidiol) products from its sustainable farm in Pueblo, Colorado. The Company’s dedication is to sustainable farming methods. Additionally, Veritas has developed its own fertilizer, which helps balance out the local ecosystem. Veritas Farms employs drip irrigation. This ensures that every plant gets the proper hydration and that the Company conserves the Rocky Mountain water it uses. Veritas does not grow from seeds; it always cultivates from mother plants. Moreover, using clones allows Veritas to maintain genetic stability.
Earlier this month, Veritas Farms announced that Fruth Pharmacy will start selling Veritas Farms™ brand hemp oil products at 15 store locations in West Virginia. Veritas Farms™ brand hemp oil products available at Fruth Pharmacy will include full spectrum tinctures, moisturizing lotions, salves, and lip balms, and popular gummies.
Last week, Veritas Farms announced that its topical products will be featured nationwide in 945 Kroger Family of Stores. This includes banners Kroger, Dillons, Fry’s, Fred Meyer, King Soopers, Mariano’s, Pick ‘n Save, QFC and Smith’s, across 17 states (Arizona, Arkansas, Colorado, Illinois, Indiana, Kansas, Kentucky, Michigan, Missouri, Nevada, Oregon, South Carolina, Tennessee, West Virginia, Washington, Wisconsin, and Wyoming).
Veritas Farms, Inc. (VFRM), closed Tuesday's trading session at $1.32, up 14.78%, on 540,428 volume with 472 trades. The average volume for the last 3 months is 98,784 and the stock's 52-week low/high is $0.1519/$1.679.
EOS, Inc. (EOSS)
OTC Markets, Barchart, Stockhouse, InvestorsHub, 4-Traders, The Street, Wolf Street, Dividend Investor, Seeking Alpha, Morningstar, MarketWatch, last10k, Stockopedia, Wallet Investor, Real Investment Advice, and Trading View reported earlier on EOS, Inc. (EOSS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
EOS, Inc. has a broad distribution network of associates with many dealer companies providing health care, beauty care, and environmentally friendly cleaning products in Asia. Since Q1 of 2017, the Company has expanded its marketing channels in China and Southeast Asian countries. Formed in 2015 and OTCQB-listed, EOS is headquartered in Taipei, Taiwan.
The Company previously acquired all of the issued and outstanding shares of Emperor Star International Trade Co. Ltd. (effective May 3, 2017). This is the trading team that plays a vital part in the supply chain of EOS products. EOS acquired Emperor Star trading company in Taipei, Taiwan to strengthen its business and prepare for the challenge of OBOR (One Belt and One Road) development in Malaysia, Indonesia, Thailand, and Cambodia. Emperor Star has been distributing highly unique health and beauty care products and environmentally friendly cleaning products, with first-rate growth in China and Asia.
EOS focuses on the marketing and distribution of skin care products to resellers in Taiwan. It engages in the distribution and marketing of skin care products manufactured by A.C. (USA), Inc. Its products include moisturizers, serums, cleansers, and toners. Products also include exfoliators, acne and oil correctors, facial masks, cleansing devices, and sun care products.
In 2017, Mr. Ben Yang, the chief representative of Asian market, EOS, Inc., signed agency contracts in Nanning City, Guangxi, China, with three owners of new flagship stores launched there. There are four flagship stores set up in China. This includes the first one in Quanzhou. This will help contribute to growing the business of EOS in China. Nanning City is the largest economy of Guangxi province.
On November 30, 2018, EOS signed a contract with A-Best Company and commenced to march toward the worldwide 3C market. A-Best Company is a foremost manufacturer of advanced Piezoelectric Ceramic Speakers.
The collaboration contract was signed by Mr. Yang He-Hsiang, President of EOS, and Mr. Lai Ying-Min, President of A-Best Wire Harness & Components Co., Ltd., at Gloria Prince Hotel in Taipei, Taiwan. The focus of this collaboration is on promoting A-Best Company's patented products, Piezoelectric Ceramic Speakers, and developing more value added products to the international 3C market.
EOS, Inc. (EOSS), closed Tuesday's trading session at $2.48, up 65.33%, on 100 volume with 1 trade. The average volume for the last 3 months is 57 and the stock's 52-week low/high is $0.55/$3.50.
Almost Never Films, Inc. (HLWD)
Street Insider, InvestorsHub, PR Newswire, Ticker Report, Penny Stock Hub, OTC Markets, The Street, YCharts, Barchart, Simply Wall St, Dividend Investor, Street Insider, Market Exclusive, MarketWatch, Marketbeat, and Equity Clock reported beforehand on Almost Never Films, Inc. (HLWD), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Almost Never Films, Inc. is an independent film company headquartered in Los Angeles, California. The Company’s emphasis is on film production, finance and production related services for movies under budgets of $35 million. Its business is to enable relationships between creative talent and companies who produce, finance and distribute motion pictures. Almost Never Films’ shares trade on the OTC Markets.
Almost Never Films’ goal is to create, acquire, or license rights to materials upon which it believes motion pictures can be based (screenplays, books, short stories, etc.). The Company has a strategic partnership with Pure Flix Entertainment. This partnership is a multi-film financing agreement to produce six faith-based original motion pictures.
Pure Flix Entertainment is a U.S. independent Christian film and television studio, based in Scottsdale, Arizona. Pure Flix Entertainment will distribute the films globally in new media format. Almost Never Films will contribute its financial, development, and production services.
Almost Never Films previously announced the release of its two faith-based films "The Prayer Box" and "Christmas Manger" (formerly named "Bethlehem Ranch") by Universal Pictures Home Entertainment, the home video distribution division of Universal Pictures. The launch of these two films marks the completion of the first two films of a multi-film financing agreement between Almost Never Films and Pure Flix Entertainment.
Recently, Almost Never Films announced that ION Television acquired the Company's holiday feature "Country Christmas Album". The network aired the film during 2018's holiday season. ION Television is a foremost family-oriented entertainment network. ION Television is a top 10-ranked U.S. general entertainment network. It is the flagship of the independent, privately held media company, ION Media. ION Media's 70 full-power stations reach 102 million homes.
The people behind Almost Never Films are originally from the finance industry. The Company is made up of private equity and investment professionals that have a passion for motion pictures.
Almost Never Films, Inc. (HLWD), closed Tuesday's trading session at $0.75, up 17.19%, on 158 volume with 2 trades. The average volume for the last 3 months is 2,728 and the stock's 52-week low/high is $0.30/$2.509.
Kutcho Copper Corp. (KCCFF)
InvestorX, Junior Stock Review, Investors Hangout, The Prospector News, Mining & Energy, Wallet Investor, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Stock Orange, Resource World, Dividend Investor, Stockhouse, Barchart, Stockwatch, and MarketWatch reported previously on Kutcho Copper Corp. (KCCFF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Kutcho Copper Corp. concentrates on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. The Company’s intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. A resource development company, Kutcho Copper is headquartered in Vancouver, British Columbia (B.C.).
The Kutcho Copper Project is Kutcho’s 100 percent owned high grade copper-zinc development project in northern B.C. This Project is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho Copper has a Probable Reserve of 10.4 Mt grading 2.01% Cu and 3.19% Zn (2.92% CuEq).
The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves and substantially increase production capacity.
The Wheaton Precious Metals stream establishes a basis for a strong partnership and lessens financial risk of the Project. Furthermore, there is the potential for more discoveries via exploration. Kutcho Copper’s objective is to increase reserves from the present 10.4 Mt through existing resource conversion.
Kutcho Copper has launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world’s largest streaming companies, a global base and precious metals and concentrates trading company and an international financial institution providing banking services in the metals and mining industry. MineHub is a leading-edge technology company taking advantage of blockchain technology to develop a new generation of applications for the metals and mining industry.
Recently, MineHub Technologies and IBM announced a collaboration to use blockchain technology to help improve operational efficiencies, logistics and financing and decrease costs in the high-value mineral concentrates supply chain - from mine to end buyer. Kutcho Copper, Goldcorp, Inc., ING Bank, Ocean Partners USA, Inc. and Wheaton Precious Metals are working with mining technology company MineHub to build the new mining supply chain solution on top of the IBM Blockchain Platform.
Also recently, Kutcho Copper announced it appointed Mr. Michael Rapsch as Vice President of Corporate Communications. Mr. Rapsch has a decade of in-depth investor relations and corporate communications experience. Before joining Kutcho Copper he held the position of Vice President, Corporate Communications at SilverCrest Metals, Inc. for the last three years.
Kutcho Copper Corp. (KCCFF), closed Tuesday's trading session at $0.1487, up 30.44%, on 8,640 volume with 5 trades. The average volume for the last 3 months is 16,681 and the stock's 52-week low/high is $0.114/$0.40369.
HedgePath Pharmaceuticals, Inc. (HPPI)
Simply Wall St, 4-Traders, Infront Analytics, Morningstar, MarketWatch, InvestorsHub, BUYINS.NET, Stockhouse, Dividend Investor, and Wallet Investor reported earlier on HedgePath Pharmaceuticals, Inc. (HPPI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company headquartered in Tampa, Florida. It discovers, develops, and plans to commercialize front-line therapeutics for patients with cancer. The Company is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. HedgePath Pharmaceuticals lists on the OTC Markets Group’s OTCQB.
HedgePath is the exclusive United States licensee of a patented formulation of itraconazole, called SUBA-Itraconazole. Clinical studies have shown it to have more bioavailability than generic itraconazole. The Hedgehog signaling pathway is a significant regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, as well as cell proliferation.
The Company believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Leveraging research undertaken by key investigators in the field, HedgePath’s plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.
The design of “SUBA technology” (which stands for “Super Bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and substantially reduced variability in comparison to generic itraconazole.
In August of 2018, HedgePath Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) confirmed HedgePath’s present clinical and regulatory pathway related to the Company’s SUBA™-Itraconazole as a treatment for Basal Cell Carcinoma (BCC) in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS, or Gorlin Syndrome).
Recently, HedgePath Pharmaceuticals announce that it entered into a revised Supply and License Agreement (SLA) with its majority stockholder Mayne Pharma Ventures Pty Ltd (Mayne Pharma), an affiliate of Mayne Pharma Group Limited. With the new SLA, Mayne Pharma will assume control of the regulatory and clinical development program for SUBA®-Itraconazole for the treatment of basal cell carcinoma nevus syndrome (SUBA-Itraconazole BCCNS) in expectation of conducting a worldwide Phase 3 pivotal clinical trial based on results attained in the Phase 2(b) trial conducted by HedgePath in the United States. Mayne Pharma will immediately assume responsibility for all future SUBA-Itraconazole BCCNS-related expenses.
HedgePath Pharmaceuticals, Inc. (HPPI), closed Tuesday's trading session at $0.07, even for the day, on 2,300 volume with 3 trades. The average volume for the last 3 months is 10,160 and the stock's 52-week low/high is $0.04015/$0.375.
Regulus Therapeutics, Inc. (RGLS)
Investor Network, Zacks, 4-Traders, Stock Twits, Stock News Gazette, Simply Wall St, YCharts, InvestorsHub, MarketWatch, Stockhouse, Nasdaq, and The Street reported earlier on Regulus Therapeutics, Inc. (RGLS), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Regulus Therapeutics, Inc. is leading the discovery and development of innovative medicines targeting microRNAs. The Company is advancing several programs in renal, hepatic and central nervous systems (CNS) diseases. A clinical stage biopharmaceutical enterprise, Regulus Therapeutics was established in September 2007 by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, now Ionis Pharmaceuticals (IONS). Regulus Therapeutics is headquartered in La Jolla, California.
Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline. This pipeline is complemented by a rich intellectual property (IP) estate. Together, this enables the Company to retain its leadership in the microRNA field.
Regulus Therapeutics has its RG-012 for Alport syndrome and RGLS4326 for autosomal dominant polycystic kidney disease (ADPKD). Alport syndrome is an inherited form of kidney disease. RG-012 is undergoing development by Regulus in a strategic alliance with Genzyme, a Sanofi company, for the treatment of Alport syndrome.
RG-012 is a single stranded, chemically modified oligonucleotide. It binds to and inhibits the function of miR-21 for the treatment of Alport syndrome. ADPKD is among the most common human monogenetic disorders. In addition, it is a leading genetic cause of end-stage renal disease. RGLS4326 is a novel oligonucleotide. The design of it is to inhibit miR-17 using an inventive chemistry design to preferentially target the kidney.
Regulus and STA Pharmaceutical Co., Ltd. (STA) entered into an oligonucleotide synthesis collaboration agreement in 2018 for research and mid-scale non-GMP/cGMP manufacturing. STA is a WuXi AppTec group company. It is the foremost open-access capability and technology platform for small molecule pharmaceutical development and manufacturing.
Recently, Regulus Therapeutics announced the nomination of RGLS5579 as a clinical candidate for the treatment of glioblastoma multiforme (GBM). RGLS5579 is a novel oligonucleotide. The design of it is to inhibit miR-10b. Preclinical studies with RGLS5579 have demonstrated direct anti-tumor effects in vitro and in vivo.
Mr. Jay Hagan, President and Chief Executive Officer of Regulus Therapeutics, said, "We are excited to announce our clinical candidate for the treatment of GBM, a devastating form of brain cancer, for which therapeutic options are extremely limited. The combination data we have generated, and repeated, may suggest that we can significantly extend expectations for survival for patients with GBM over the current standard of care."
Regulus Therapeutics, Inc. (RGLS), closed Tuesday's trading session at $1.18, up 19.43%, on 337,858 volume with 1,029 trades. The average volume for the last 3 months is 176,510 and the stock's 52-week low/high is $0.80/$8.99.
EPHS Holdings, Inc. (STNN)
MarketWatch, YCharts, Dividend Investor, last10k, Simply Wall St, Stockopedia, The Stock Market Watch, The Street, Street Insider, Market Chameleon, Stockwatch, InvestorsHub, GuruFocus, Wallet Investor, Morningstar, and Marketbeat reported earlier on EPHS Holdings, Inc. (STNN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
EPHS Holdings, Inc., via its subsidiary, Emerald Plants Health Source, Inc., intends to cultivate and distribute cannabis in Canada. The Company’s aim is to secure a commercial cultivation license identified as a license for access to cannabis for medical purposes regulation (ACMPR). OTCQB-listed, EPHS Holdings is headquartered in Boynton Beach, Florida.
Only upon receipt of the ACMPR may the Company commence its commercial operations. After Health Canada grants EPHS its ACMPR license, the Company will begin cultivation of its first cannabis crops.
The initial crops will be submitted to Health Canada as part of the Company’s application for a sales license. EPHS plans to begin commercial sales within four months of receiving the ACMPR license.
Emerald Plants Health Source is EPHS Holdings’ sole operating subsidiary. Emerald is based in the Province of Quebec. It conducts its operations entirely within Canada. Upon Emerald obtaining its ACMPR, it will be required to apply for an additional sales license.
Recently, EPHS Holdings, together with its joint venture (JV) partner, Merritt Valley Cannabis, announced it received approval for their pending commercial cultivation license, (ACMPR), from Health Canada. The license was received on Friday, October 12, 2018. EPHS may now produce cannabis for medicinal and recreational purposes. This includes licensed products such as dried or fresh cannabis flower, cannabis oil, starting materials and plants at EPHS’s state-of-the art facility in Quebec.
Also recently, EPHS Holdings, together with its JV partner, Merritt Valley Cannabis, announced its Montreal cultivation plans started, as per Health Canada sales license regulations and inspections. The EPHS state-of-the-art facility in Montreal is ready for immediate production and scale. EPHS is starting with the Health Canada sales license process.
EPHS will continue to scale cannabis production at its Merritt site with the granting of additional Health Canada licenses. Ground breaking is scheduled for early this year for Phase one of the 30,000 square foot Cannabis Campus. The expectation is that the campus will produce a supply of 5,500 plus kilograms of cannabis per year by early 2020.
EPHS Holdings, Inc. (STNN), closed Tuesday's trading session at $0.79, up 14.49%, on 2,155 volume with 4 trades. The average volume for the last 3 months is 4,860 and the stock's 52-week low/high is $0.50/$4.40.
WRIT Media Group, Inc. (WRIT)
SeriousTraders, Tip.us, Real Pennies, StocksToBuyNow, Pennystockmania, Great Penny Picks, and SmallCapVoice reported earlier on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.
WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.
WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.
Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.
WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.
Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.
WRIT Media's development team has also recently built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.
WRIT Media Group, Inc. (WRIT), closed Tuesday's trading session at $0.0267, up 20.27%, on 1,501 volume with 2 trades. The average volume for the last 3 months is 4,124 and the stock's 52-week low/high is $0.009/$0.10.
The QualityStocks Company Corner
- MustGrow Biologics Corp.
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Marijuana Company of America Inc. (MCOA)
- SinglePoint, Inc. (SING)
- Sugarmade, Inc. (SGMD)
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Geyser Brands Inc. (TSX.V: GYSR)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)
- VPR Brands, LP (VPRB)
MustGrow Biologics Corp.
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients?(http://nnw.fm/Qkz21).?For the past 50 years,?nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
- MustGrow Biologics Corp. Building Suite of Natural Biologic Agriculture Products to Protect Global Cannabis, Fruit & Vegetable Crops
- QualityStocksNewsBreaks – MustGrow Biologics Corp. Developing Natural, Patented Biopesticide as Global Market Rises
- MustGrow Biologics Corp. Commercializing Patented Natural Biopesticide in Global Market on Course to Reach $6.4B by 2023
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI) today announced its entry into an exclusive agreement with Feather Company Ltd., a cannabis innovator and lifestyle brand committed to the production of premium-quality products that enhance the cannabis experience for customers. To view the full press release, visit: http://nnw.fm/1vKrZ. Also today, the company was highlighted in the latest edition of Investorideas.com potcastsCM - examining cannabis news and stocks to watch plus insight from thought leaders and experts http://ibn.fm/q19Up.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $6.44, up 3.54%, on 355,958 volume with 2,757 trades. The average volume for the last 3 months is 1,062,768 and the stock's 52-week low/high is $6.15/$8.44.
- NetworkNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Enters Exclusive Agreement with Cannabis Innovator Feather Company Ltd.
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move June 18th
- CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)
TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE: TH8) ("TransCanna" or the "Company") has hired Alan R. Applonie as General Manager. Alan will be responsible for all activities in the manufacturing operations of the Company's recently acquired 196,000 sq. ft. vertically integrated cannabis-focused facility, as well as other facilities and operations the Company may acquire in Stanislaus County. Also today, CannabisNewsWire released a report on the company detailing how the cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets.
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.
TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.
The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.
Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.
The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.
TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.
Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).
TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.
Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.
Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.
Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.
The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.
TransCanna Holdings Inc. (CSE: TCAN), closed Tuesday's trading session at $5.14, up 3.84%, on 157,904 volume with 180 trades. The average volume for the last 3 months is 152,904 and the stock's 52-week low/high is $0.77/$7.79.
- TransCanna Hires General Manager for Its 196,000 Sq Ft Facility; Bringing Decades Of Experience In Consumer Goods Products
- Acquisitions Reveal the Steadily Changing Shape of the Cannabis Sector
- NetworkNewsBreaks – TransCanna Holdings Inc.’s (CSE: TCAN) (FSE: TH8) Lyfted Acquisition Puts ‘Finger in Many Pies’
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) grows high-quality, organic cannabis with sustainable, all-natural principles. A premium global organic cannabis company headquartered in Mississauga, Ontario, TGOD focuses on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD’s products are laboratory tested to ensure that patients have access to a standardized, safe, consistent product. The company’s organic process involves transparent, sustainable steps and principles to produce certifiable quality.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Tuesday's trading session at $2.485, up 4.41%, on 385,954 volume with 637 trades. The average volume for the last 3 months is 929,384 and the stock's 52-week low/high is $1.607/$7.89.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Secures Cannabis Supply Agreement
- NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces 2019 AGM Voting Results, Enters Multi-Year Agreement with Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT)
- Cannabis Stocks to Watch: Green Organic Dutchman (OTCQX:TGODF) Up +1.14% Monday
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood, Inc. (OTCQB: NGTF), the innovative ice cream company solving America’s $50 billion-dollar nighttime snacking problem, today announced another major supermarket chain will soon be carrying Nightfood ice cream. The new chain has agreed to place Nightfood in 100% of their 250+ locations. As with past supermarket chain announcements, Nightfood will not announce the name of their new retail partner until product is available in stores. The award-winning ice cream is expected to hit shelves in early September.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Tuesday's trading session at $0.387, up 1.84%, on 125,465 volume with 69 trades. The average volume for the last 3 months is 250,571 and the stock's 52-week low/high is $0.2483/$0.7915.
- Nightfood Lands Another Top-50 Supermarket Chain; Placing Nightfood Ice Cream This Summer in All 250+ Stores
- Nightfood National Supermarket Rollout Supported by Moms Meet, Introducing Nightfood to Almost Two Million Moms Across the Country
- Nightfood Ice Cream Announced as Multiple-Category Finalist in World Dairy Innovation Awards 2019
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Tuesday's trading session at $0.0116, up 0.94%, on 3,359,748 volume with 184 trades. The average volume for the last 3 months is 3,359,748 and the stock's 52-week low/high is $0.0103/$0.049.
- Marijuana Company of America and Joint Venture Partner Global Hemp Group Announce Start of Commercial Planting at Hemp Farm
- U.S. Hemp Industry Revenues Continue To Rise Generating Amazing Opportunities
- 420 with CNW – Mississippi Medical Cannabis Ballot Measure Close to Attaining Signature Target
SinglePoint, Inc. (SING)
SinglePoint Inc. (OTCQB: SING) is pleased to announce Direct Solar has surpassed everyone’s expectations signing contracts to deploy $1,709,460 in solar installs over the previous 30 days. This revenue should generate approximately $803,769 in gross and $361,541 in net. Operating in just six states and all residential installs, the company has plenty of new opportunities and areas to grow in. Over the course of the next week, Direct Solar will add two more states – Missouri and Florida. The two new states should drive additional revenue and continue the explosive growth of Direct Solar.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.0118, up 9.06%, on 6,309,656 volume with 185 trades. The average volume for the last 3 months is 3,933,112 and the stock's 52-week low/high is $0.0101/$0.21.
- In First 30 Days of Direct Solar Purchase, SinglePoints route to Profitability, Projecting $7,000,000 Revenue in 2019, Achieved $1,709,460 in Trailing 30 Days
- SinglePoint Inc. (SING) Focused on Acquiring Companies that Benefit from Technology Integration, Growth Capital Injection
- NetworkNewsBreaks – SinglePoint Inc.’s (SING) Strategics Program Paving Way for Qualified CBD Companies
Sugarmade, Inc. (SGMD)
The health and wellness market sector for cannabidiol (CBD) products continues to grow at such a pace that analysts at the Brightfield Group predict that revenues could reach $22 billion per year by 2022 and, per various Wall Street estimates, approach $50 billion or even $75 billion by 2029-30, as noted in a media report carried by Nasdaq (http://nnw.fm/Lev70). The potency of CBD’s sales estimates are encouraging to Sugarmade Inc. (OTCQB: SGMD), which announced this month that it is expanding on its hydroponics supply model for the agriculture industry to enter the hemp extraction equipment and technologies market (http://nnw.fm/1qlSN).
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.0315, off by 7.62%, on 840,375 volume with 60 trades. The average volume for the last 3 months is 1,675,707 and the stock's 52-week low/high is $0.02/$0.20.
- Sugarmade Inc. (SGMD) Entering Hemp CBD Extraction Equipment Market with Chinese Technological Backup
- Sugarmade Inc. Featured in CannabisNewsAudio Broadcast on Importance of CBD Extraction Providers
- Sugarmade to Enter Market for Hemp Extraction Technologies and Equipment
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
Canadian cannabis cultivation firm the Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Monday announced its receipt of a loan commitment from an ATB Financial (“ATB”) syndicate of lenders as lead arranger and administrative agent for up to $50,000,000 of committed senior secured credit facilities. To view the full press release, visit: http://nnw.fm/9ksfP.
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.
Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.
Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.
Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.
In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.
Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.
Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:
- FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
- Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
- Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.
Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.
Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.
The Flowr Corporation (TSX.V: FLWR), closed Tuesday's trading session at $5.38, up 0.19%, on 38,928 volume with 164 trades. The average volume for the last 3 months is 81,307 and the stock's 52-week low/high is $2.18/$6.30.
- NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Receives Loan Commitment for $50M Senior Secured Credit Facilities
- NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) CEO to Participate in Panel Discussion at Piper Jaffray’s 39th Annual Consumer Marketplace Conference
- Flowr to Participate on Cannabis Panel at the Piper Jaffray Consumer Marketplace Conference on June 6, 2019
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) welcome's Health Canada's final regulations for new cannabis products ("Health Canada's Regulations") and reiterates its expanded product strategy.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $1.15, off by 0.82%, on 339,261 volume with 501 trades. The average volume for the last 3 months is 466,284 and the stock's 52-week low/high is $0.85/$2.04.
- Supreme Cannabis Well-Positioned for Health Canada's Final Regulations for New Cannabis Products
- NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Positioned to Deliver Innovative Products Worldwide
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Enters Canada’s Vaporizer Market through Strategic Partnership
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands (TSX.V: GYSR) today announced receipt of a coveted Health Canada Standard Processing License by its wholly owned Licensed Producer, 0957102 B.C. Ltd. dba Apothecary Botanicals. According to the update, the license will enable expansion of the company’s long term vision and commencement of the manufacturing of premier products, including tinctures and supplements. To view the full press release, visit: http://nnw.fm/zbV3J.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Tuesday's trading session at $0.58, off by 7.94%, on 4,667 volume with 4 trades. The average volume for the last 3 months is 8,433 and the stock's 52-week low/high is $0.33/$0.85.
- NetworkNewsBreaks – Geyser Brands Inc.’s (TSX.V: GYSR) Apothecary Botanicals Awarded Processing License
- NetworkNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Aims to Become Leading Provider of Health-Focused CBD, Hemp Products
- Geyser Brands Inc. (TSX.V: GYSR) Plans to Utilize NanoFusion Technology in World’s First Hemp-Infused Pet Food Product
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Searching for the Next Super Nova,” please visit: http://cnw.fm/RJm5s. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. The Veterans and Legal Affairs Committee of Maine’s Assembly has voted 7-2 approving the draft rules for the legalization of recreational marijuana in the state. The approved rules relax the residency requirements included with the purpose of keeping out-of-state companies from moving in and controlling the recreational market at the expense of local companies.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Tuesday's trading session at $0.47, off by 3.07%, on 96,786 volume with 23 trades. The average volume for the last 3 months is 23,779 and the stock's 52-week low/high is $0.009/$1.129.
- Wildflower Featured in CannabisNewsWire Publication Highlighting Legal Cannabis as a Global Profit Phenomenon
- 420 with CNW – Maine Relaxes Residency Requirements for Recreational Marijuana Companies
- Wildflower Expands Nationwide Retail Presence with Dillard’s Department Stores
Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)
There are many multi-state operators seeking a slice of the $14.5 billion U.S. cannabis industry, but few have the ambition and expertise of Nabis Holdings Inc. (CSE: NAB) (OTC Pink: INNPF) (FSE: 7IP). Staying true to its name, meaning 'repeat performance' or 'encore', the co-founders behind MPX Bioceuticals Corp., which was purchased by iAnthus Capital Holdings Inc. for C$835 million, is looking to repeat and exceed its success.
Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."
While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.
Criteria for investment targets are as follows:
- Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
- Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
- Identifying proven operators with good expertise to add value to a consolidation strategy
- Focused on MSOs (Multi-state Operators) with strong brand traction
- Pharma grade cultivation, extraction, dispensaries and other addressable operations
Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.
Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.
Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.
Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.
Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.
Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.
Proven Management Team
CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.
President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.
Nabis Holdings (OTC: INNPF), closed Tuesday's trading session at $0.2604, off by 1.74%, on 207,369 volume with 68 trades. The average volume for the last 3 months is 186,767 and the stock's 52-week low/high is $0.025/$0.7915.
- Nabis Expands National Footprint with California Acquisition-- CFN Media
- Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Develops Vertically Integrated Cannabis Portfolio, Forecasts Revenue Growth
- Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
VPR Brands, LP (VPRB)
VPR Brands LP (OTC: VPRB) today announces the availability of its Guide to 2020 U.S. Presidential Candidates on Cannabis Issues. The 2020 presidential election is the first in which candidates find themselves, willingly or not, taking controversial public positions on cannabis issues. As voters begin to gather information on next year’s election, VPR Brands has sponsored a guide to provide an in-depth look at each candidate’s stance on cannabis. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Tuesday's trading session at $0.06, off by 2.12%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 75,779 and the stock's 52-week low/high is $0.026/$0.14.
- VPR Brands LP (VPRB) Releases Cannabis Voters’ Guide to 2020 Presidential Candidates
- 420 with CNW – Maine Relaxes Residency Requirements for Recreational Marijuana Companies
- VPR Brands LP (VPRB) Fostering Steady Year-over-Year Growth
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Renews Access Agreements for Port and Power & Provides Project Update
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) in Final Negotiations to Significantly Expand Cannabis Cultivation and Retail Operations
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Grant of Incentive Stock Options
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Resignation of Non-Executive Chairman
- ChineseInvestors.com (CIIX) Projects Continued Revenue Growth for FY2020
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Surpasses $49,000 in Opening Day Sales at the Niagara Flagship Cannabis Store
- City View Green Holdings Inc. (CSE: CVGR) Anticipates Completion of Brantford Facility Build-Out
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Earth Science Tech, Inc. (ETST) 420 with CNW – Church of England Starts Investing in Marijuana
- Endonovo Therapeutics (OTCQB: ENDV) Positioned to Benefit as Wearable Medical Devices Market Projected to Reach $66.8 Billion by 2026
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Opens Demonstration Center to Investors
- Genprex Inc. (NASDAQ: GNPX) Advances Toward Lead Drug
- Geyser Brands Inc. (TSX.V: GYSR) Aims to Become Leading Provider of Health-Focused CBD, Hemp Products
- Golden Developing Solutions, Inc. (DVLP) Updates Financial Performance, Signals 160% Overall Growth Across Multiple Segments
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Consumer Cannabis Spending Should Spur Increase In Dispensaries And Cultivation Operations In 2019
- Green Hygienics Holdings Inc. (GRYN) Registered to Cultivate Industrial Hemp in San Diego County, California
- QualityStocksNewsBreaks – Hemptown USA Positioned as Leading Producer of CBG — Potential Next Big Thing
- INmune Bio, Inc. (NASDAQ: INMB) Featured in Exclusive NetworkNewsWire Broadcast
- IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF) Completes Acquisition of Vegas Valley Growers North
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) DehydraTECH: The Cynosure of Efficient CBD Delivery -- CFN Media
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Mississippi Medical Cannabis Ballot Measure Close to Attaining Signature Target
- MustGrow Biologics Corp. is “One to Watch”
- Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Enters Definitive Agreement to Acquire Desert Hot Springs, California Dispensary
- Net Element, Inc. (NASDAQ: NETE) Launches Artificial Intelligence-Based Underwriting Solution
- Nightfood, Inc. (OTCQB: NGTF) National Supermarket Rollout Supported by Moms Meet, Introducing Nightfood to Almost Two Million Moms Across the Country
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Featured in NetworkNewsAudio Broadcast on Growth of Indonesian Nickel Market
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Revolutionizing Oil, Gas Industry with Environmentally Friendly Production Platform
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Offers Secured Loan for Option to Buy Cannabis Oil Manufacturer
- Pressure BioSciences Inc. (PBIO) PCT Platform Prominently Featured in Record Number of Presentations at Major International Science Conference
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Assay Results Suggest Further Tonnage at Irgon Property
- Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) Notes from the Floor: Lift Cannabis Business Conference Toronto
- Sharing Services Global Corporation (SHRG) Empowers Elepreneurs to Achieve Wellness in Both Mind and Body
- SinglePoint, Inc. (SING) Focused on Acquiring Companies that Benefit from Technology Integration, Growth Capital Injection
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Advancing Unique Commercial Cellular Device for Public Safety and Commercial Fleet Vehicles
- Spectrum Global Solutions, Inc. (SGSI) Bundled Services Strategy Provides Edge in Telecommunications Growth Market
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces First Commercial Sale of Cannabis Flower
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Provides Progress Update on its Industrial-Scale Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Featured in CannabisNewsAudio Broadcast on Importance of CBD Extraction Providers
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Positioned to Deliver Innovative Products Worldwide
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) CEO to Participate in Panel Discussion at Piper Jaffray’s 39th Annual Consumer Marketplace Conference
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces 2019 AGM Voting Results, Enters Multi-Year Agreement with Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT)
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Missouri Puts Final Touches to Medical Marijuana Rules
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Lyfted Acquisition Puts ‘Finger in Many Pies’
- Trxade Group Inc. (TRXD) Subsidiary Secures LegitScript Certification
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Subsidiary’s Project Moves to 2nd Phase of Health Canada Review, Approval
- VPR Brands, LP (VPRB) Fostering Steady Year-over-Year Growth
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Nationwide Retail Presence with Dillard’s Department Stores
- Youngevity International, Inc. (NASDAQ: YGYI) Khrysos Industries, Inc., a wholly owned subsidiary of Youngevity International, Enters Into a 5-Year Supply Contract to purchase Hemp Plant Biomass for Extraction, Processing and Production of Hemp-Derived Products
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.